Diffuse dark brown discoloration of gastric fundic gland mucosa following proton pump inhibitor therapy
- PMID: 40483644
- DOI: 10.1007/s12328-025-02156-5
Diffuse dark brown discoloration of gastric fundic gland mucosa following proton pump inhibitor therapy
Abstract
Herein, we report a case in which diffuse dark brown discoloration was observed throughout the gastric fundic gland mucosa on endoscopy 2 years after the initiation of proton pump inhibitor (PPI) therapy. In addition, scattered dark brown spots were observed within the area of diffuse discoloration. These lesions were significantly more pronounced on the Texture and Color Enhancement Imaging mode 1. These changes were not observed before the initiation of PPI therapy or in the antrum after PPI administration. Biopsy specimens from the discolored mucosa revealed lipofuscin granules in the cytoplasm of the parietal cells. These findings suggest that the discoloration was a result of the deposition of lipofuscin due to the action of PPI on parietal cells. To the best of our knowledge, these findings have not been previously reported and are distinct from those of black spots and gastric pseudomelanosis. We believe that these new findings offer valuable insights into gastric mucosal changes associated with PPI therapy.
Keywords: Dark brown spot; Diffuse dark brown discoloration; Lipofuscin; Pigmentation; Proton pump inhibitor.
© 2025. The Author(s), under exclusive licence to Japanese Society of Gastroenterology.
Conflict of interest statement
Declarations. Conflict of interest: The authors have no conflict of interest.
Similar articles
-
Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors.Aliment Pharmacol Ther. 2016 Nov;44(9):915-925. doi: 10.1111/apt.13800. Epub 2016 Sep 15. Aliment Pharmacol Ther. 2016. PMID: 27634363
-
Proton pump inhibitors reduce nivolumab efficacy in unresectable advanced or recurrent gastric cancer.Immunotherapy. 2025 Apr;17(5):331-338. doi: 10.1080/1750743X.2025.2491300. Epub 2025 Apr 14. Immunotherapy. 2025. PMID: 40228034
-
Black Spot, a Novel Gastric Finding Potentially Induced by Proton Pump Inhibitors.Intern Med. 2016;55(21):3079-3084. doi: 10.2169/internalmedicine.55.6974. Epub 2016 Nov 1. Intern Med. 2016. PMID: 27803398 Free PMC article.
-
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions.Cochrane Database Syst Rev. 2014 Dec 2;2014(12):CD010623. doi: 10.1002/14651858.CD010623.pub2. Cochrane Database Syst Rev. 2014. PMID: 25464111 Free PMC article.
-
Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease.Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD015127. doi: 10.1002/14651858.CD015127.pub2. Cochrane Database Syst Rev. 2025. PMID: 40066936
References
-
- Shanika LGT, Reynolds A, Pattison S, et al. Proton pump inhibitor use: systematic review of global trends and practices. Eur J Clin Pharmacol. 2023;79:1159–72.
-
- Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153:35–48.
-
- Kato M. PPI-related gastropathy. Kyoto classification of gastritis. 2nd ed. Tokyo: Nihon Medical Center; 2018. p. 96–9 (in Japanese).
-
- Ayaki M, Haruma K. Black spot. Kyoto classification of gastritis. 3rd ed. Tokyo: Nihon Medical Center; 2023. pp.106–7 (in Japanese).
-
- Hatano Y, Haruma K, Ayaki M, et al. Black spot, a novel gastric finding potentially induced by proton pump inhibitors. Intern Med. 2016;55:3079–84.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical